Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the learndash domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/oquhzfvtvrzo/public_html/wp-includes/functions.php on line 6114

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the login-customizer domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/oquhzfvtvrzo/public_html/wp-includes/functions.php on line 6114

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the astra domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/oquhzfvtvrzo/public_html/wp-includes/functions.php on line 6114
Risks of attempting TFR – Leukaemia Care e-learning

Risks of attempting TFR

By /

In clinical trials, including EURO-SK4 and ENESTFreedom, 25–30% of patients who stopped taking any TKI experienced a ‘TKI withdrawal syndrome’ – pain localised to various parts of the body, including the hips, shoulders and extremities, resembling polymyalgia rheumatica. Most patients can manage these symptoms with paracetamol and non-steroidal anti-inflammatory drugs, although some require steroids. It is thought that off-target effects of TKIs in inhibiting the receptor tyrosine kinase cKIT relieves some joint inflammation, which returns upon TKI withdrawal. Supporting this link, some patients with spondyloarthritis achieve pain relief with nilotinib.